Apini Therapeutics
PrivateLast Round
Seed
Jun 11, 2025
Company Overview
Apini Therapeutics operates in Healthcare & Life Sciences and is based in Manchester. Its latest recorded funding round was an Accelerator round in November 2024.
Apini Therapeutics is a biotechnology company that develops small molecule compounds for the treatment of chronic inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apini Therapeutics Comparables
Compare Apini Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensho Therapeutics | 81% | |
| Micromune Therapeutics | 80% | |
| Cibus Therapeutics | 79% |
For institutional investors. Book with your work email.
Apini Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Apini Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Seed, Accelerator |
| Northern Gritstone | Seed |
| The University of Manchester Innovation Factory | Accelerator |
Apini Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Apini Therapeutics's valuation, stock price, and market status.
Is Apini Therapeutics a public or private company?
Apini Therapeutics is a private company.
What is the current stock price of Apini Therapeutics?
Apini Therapeutics is a private company, so its shares have no public market price. Caplight tracks Apini Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Apini Therapeutics worth (valuation)?
Valuation information for Apini Therapeutics is not publicly available.
Can I buy Apini Therapeutics stock?
Apini Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Apini Therapeutics's last funding round?
Apini Therapeutics's most recent funding round was Seed on June 11, 2025.
Who are the main investors in Apini Therapeutics?
Key investors in Apini Therapeutics include Syncona, Northern Gritstone.
Will Apini Therapeutics IPO soon?
No public IPO plans have been announced for Apini Therapeutics.
How can I track Apini Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Apini Therapeutics's shares on secondary markets.